相关实验视频
Updated: Jun 13, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.0K
变化贝叶斯机器学习用于一般结果指标的风险调整,在泌尿病学中举例
Harvey Jia Wei Koh1,2,3, Dragan Gašević1,2, David Rankin2,3
1Centre for Learning Analytics, Faculty of Information Technology, Monash University, Clayton, VIC, Australia.
NPJ digital medicine
|September 14, 2024
概括
我们开发了VIRGO,这是一个新的AI模型,用于调整医疗保健质量指标中的风险. 它通过解释影响结果的患者因素和表达预测不确定性来提供更公平的评估.
科学领域:
- 医疗保健中的人工智能
- 医疗保健服务研究 医疗服务研究
- 临床信息学 临床信息学
背景情况:
- 对于质量指标的传统风险调整模型往往过于简单化.
- 这些模型难以解释影响结果的复杂,无法控制的患者因素.
- 准确的风险调整对于向医疗保健专业人员提供公平反至关重要.
研究的目的:
- 引入VIRGO,一种新的变异贝叶斯模型,用于对结果质量指标的个性化风险调整.
- 为了利用大型的行政数据集进行培训,一个复杂的风险调整工具.
- 提高医疗保健质量评估的公平性和准确性.
主要方法:
- 开发了一个在大型行政数据集上训练的变量贝叶斯模型 (VIRGO).
- 利用详细的人口统计,诊断和程序代码进行个性化风险调整.
- 整合了可解释的AI功能,用于识别影响结果的患者因素.
主要成果:
- 在外部数据集上,VIRGO实现了最先进的性能.
- 该模型提供了个性化的风险调整,并解释了患者因素.
- 维尔戈在表达不确定性和反事实分析方面表现出能力.
结论:
- 维尔戈提供先进的风险调整,提高医疗保健质量指标的公平性.
- 该模型的可解释性使临床医生能够理解导致不良结果的因素.
- 维尔戈通过强调无法解释的结果差异来促进对临床实践的反思.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Kaplan-Meier Approach
111
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
111
Actuarial Approach
68
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
68
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Comparing the Survival Analysis of Two or More Groups
162
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
162
Hazard Rate
95
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
95

